Period Ending | Dec 30, 2012 | Sep 29, 2012 | Jun 29, 2012 | Mar 30, 2012 |
---|
Total Revenue
|
29,304,000
|
24,747,000
|
25,783,000
|
24,673,000
| Cost of Revenue | 14,137,000 | 13,016,000 | 13,501,000 | 13,555,000 | |
Gross Profit
|
15,167,000
|
11,731,000
|
12,282,000
|
11,118,000
| |
|
Operating Expenses |
|
Research Development | 1,580,000 | 1,534,000 | 1,587,000 | 1,601,000 |
|
Selling General and Administrative | 5,694,000 | 5,607,000 | 5,547,000 | 5,631,000 |
|
Non Recurring |
-
|
-
|
-
|
-
|
|
Others |
-
|
-
|
-
|
-
|
|
|
|
Total Operating Expenses |
-
|
-
|
-
|
-
| | |
Operating Income or Loss
|
7,893,000
|
4,590,000
|
5,148,000
|
3,886,000
| |
|
Income from Continuing Operations |
|
Total Other Income/Expenses Net | 47,000 | 606,000 | 132,000 | 58,000 |
|
Earnings Before Interest And Taxes | 7,940,000 | 5,198,000 | 5,277,000 | 3,946,000 |
|
Interest Expense | 109,000 | 124,000 | 116,000 | 110,000 |
|
Income Before Tax | 7,831,000 | 5,074,000 | 5,161,000 | 3,836,000 |
|
Income Tax Expense | 1,998,000 | 1,251,000 | 1,280,000 | 769,000 |
|
Minority Interest |
-
|
-
|
-
|
-
|
|
|
|
Net Income From Continuing Ops | 5,833,000 | 3,823,000 | 3,881,000 | 3,067,000 | |
|
Non-recurring Events |
|
Discontinued Operations |
-
|
-
|
-
|
-
|
|
Extraordinary Items |
-
|
-
|
-
|
-
|
|
Effect Of Accounting Changes |
-
|
-
|
-
|
-
|
|
Other Items |
-
|
-
|
-
|
-
| | |
Net Income
|
5,833,000
|
3,823,000
|
3,882,000
|
3,066,000
| Preferred Stock And Other Adjustments |
-
|
-
|
-
|
-
| |
Net Income Applicable To Common Shares
|
5,833,000
|
3,823,000
|
3,882,000
|
3,066,000
|
|